University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion

Not Applicable

Completed

Conditions: Abortion

Interventions: Behavioral: Immediate initiation of OCPs
Behavioral: Delayed initiation of OCPs

First Posted Date: 2005-10-10

Last Posted Date: 2012-11-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 300

Registration Number: NCT00235534

Locations: 🇺🇸
Women's Options Clinic at San Francisco General Hospital, San Francisco, California, United States

Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion

Not Applicable

Completed

Conditions: Abortion

Interventions: Behavioral: timing of initiation of transdermal patch after an abortion

First Posted Date: 2005-10-10

Last Posted Date: 2019-08-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 298

Registration Number: NCT00235547

Locations: 🇺🇸
Women's Options Clinic at San Francisco General Hospital, San Francisco, California, United States

The Young Woman's Reach Project: Trial of an Intervention to Impact Contraceptive Behavior, Unintended Pregnancy, and Sexually Transmitted Infections (STIs) Among Adolescent Females

Not Applicable

Completed

Conditions: Sexually Transmitted Diseases
Contraceptive Behavior

Interventions: Behavioral: follow-up phone counseling

First Posted Date: 2005-10-03

Last Posted Date: 2012-12-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 800

Registration Number: NCT00230880

Locations: 🇺🇸
New Generation Health Center/UCSF, San Francisco, California, United States

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Phase 2

Terminated

Conditions: Gastrointestinal Carcinoid Tumor
Islet Cell Tumor
Lung Cancer
Neoplastic Syndrome
Neuroendocrine Tumor

Interventions: Biological: bevacizumab
Drug: 5-fluorouracil
Drug: leucovorin
Drug: oxaliplatin

First Posted Date: 2005-09-28

Last Posted Date: 2023-05-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 36

Registration Number: NCT00227617

Locations: 🇺🇸
Kaiser Permanente Medical Center - Vallejo, Vallejo, California, United States
🇺🇸
Univeristy of California, San Francisco, San Francisco, California, United States

A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus

Phase 2

Terminated

Conditions: Oral Lichen Planus

First Posted Date: 2005-09-26

Last Posted Date: 2023-11-08

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00226174

Locations: 🇺🇸
University of California, San Francisco, California, United States

Trachoma Elimination Follow-up

Phase 4

Completed

Conditions: Trachoma
Chlamydia

First Posted Date: 2005-09-22

Last Posted Date: 2015-07-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20000

Registration Number: NCT00221364

Locations: 🇪🇹
ORBIS-Ethiopia, Addis Ababa, Ethiopia

Intensive Intervention for Smokers - 6

Not Applicable

Completed

Conditions: Tobacco Use Disorder
Alcohol Dependence

Interventions: Other: Usual Care
Behavioral: Extended cognitive behavior therapy

First Posted Date: 2005-09-22

Last Posted Date: 2017-11-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 162

Registration Number: NCT00217984

Locations: 🇺🇸
VA Medical Center, San Francisco, California, United States

Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2005-09-22

Last Posted Date: 2013-08-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 300

Registration Number: NCT00218699

Locations: 🇺🇸
UCSF AIDS Health Project, San Francisco, California, United States

Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain

Phase 3

Completed

Conditions: Opioid Use
Postoperative Delirium
Hospital Length of Stay
Postoperative Pain

Interventions: Drug: Gabapentin

First Posted Date: 2005-09-22

Last Posted Date: 2020-09-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 750

Registration Number: NCT00221338

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Cognitive behavioral intervention
Behavioral: Standard counseling

First Posted Date: 2005-09-22

Last Posted Date: 2012-05-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 488

Registration Number: NCT00218712

Locations: 🇺🇸
SFDPH San Francisco City Clinic, San Francisco, California, United States
🇺🇸
UCSF AIDS Health Project, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy